Clinical Trial Update: A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1 [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial comparing TAS-114 plus S-1 versus S-1 alone in advanced or metastatic non-small cell lung cancer has posted results. The sponsor is T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• TAS-114

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Advanced or Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-12-23